June 07, 2010
Newer Drugs Beat Gleevec in Head-to-Head
TrialsTwo new drugs, dasatinib
(Sprycel) and nilotinib (Tasigna), appear better than imatinib
(Gleevec) in treating patients with newly diagnosed chronic myeloid
leukemia and should be considered as first-line treatments, two new
studies show.
Kids With Lesbian Parents Do Just FineWhen compared to teens of the
same age, adolescents raised by lesbian parents are doing just fine
socially, psychologically and academically, new research finds.
Novel Drug Combats Advanced MelanomaScientists say that a new
drug to treat melanoma, the first in its class, improved survival
by 68 percent in patients whose disease had spread from the skin to
other parts of the body.
40-Year-Old Gout Drug Shows Promise Against
AnginaA new British study suggests
that a standard treatment for gout, already in use for four
decades, could be an effective and less expensive alternative to
conventional drugs targeting chronic stable angina.
Secondhand Smoke a Mental Health Hazard?Long linked to physical
ailments such as asthma, heart disease and lung cancer, secondhand
smoke may now be tied to an increase in mental woes, new research
suggests.